Simultaneous deficiency of apo AI and apo CIII causes a dual defect in lipoprotein metabolism, leading to exceedingly low HDL levels and premature atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Should not change dyslipidemia management; leaves open the role of combined apo AI/CIII deficiency in atherosclerosis risk.
Forte et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: